1. Frosch E, Kelly P. Issues in pediatric psychiatric emergency care. In: Emergency psychiatry. Cambridge, UK: Cambridge University Press; 2011:185-199. 2. American College of Emergency Physicians. Pediatric mental health emergencies in the emergency department. https://www.acep.org/patient-care/policy-statements/pediatric-mental-health-emergencies-in-the-emergency-medical-services-system/ . Revised September 2018. Accessed February 23, 2019. 3. Voepel-Lewis, T, Burke C, Hadden S, et al. Nurses’ diagnoses and treatment decisions regarding care of the agitated child. J Perianesth Nurs. 2005;20 (4):239-248. 4. Malas N, Spital L, Fischer J, et al. National survey on pediatric acute agitation and behavioral escalation in academic inpatient pediatric care settings. Psychosomatics. 2017;58(3):299-306. 5. Famularo R, Kinscherff R, Fenton T. Symptom differences in acute and chronic presentation of childhood post-traumatic stress disorder. Child Abuse Negl. 1990;14(3):439-444. 6. Kaminer D, Seedat S, Stein DJ. Post-traumatic stress disorder in children. World Psychiatry. 2005;4(2):121-125. 7. Ninan A, Stewart SL, Theall LA, et al. Adverse effects of psychotropic medications in children: predictive factors. J Can Acad Child Adolesc Psychiatry. 2014;23(3):218-225. 8. Pringsheim T, Hirsch L, Gardner D, et al. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers. Can J Psychiatry. 2015;60(2):52-61. 9. Vareilles D, Bréhin C, Cortey C, et al. Hallucinations: Etiological analysis of children admitted to a pediatric emergency department. Arch Pediatr. 2017;24(5):445-452. 10. Bartlett J. Childhood-onset schizophrenia: what do we really know? Health Psychol Behav Med. 2014;2(1):735-747. 11. Diler RS, Goldstein TR, Hafeman D, et al. Distinguishing bipolar depression from unipolar depression in youth: Preliminary findings. J Child Adolesc Psychopharmacol. 2017;27(4):310-319. 12. Dervic K, Garcia-Amador M, Sudol K, et al. Bipolar I and II versus unipolar depression: clinical differences and impulsivity/aggression traits. Eur Psychiatry. 2015;30(1):106-113. 13. Masi L, Gignac M ADHD and DMDD comorbidities, similarities and distinctions. J Child Adolesc Behav2016;4:325. 14. Kendrick JG, Goldman RD, Carr RR. Pharmacologic management of agitation and aggression in a pediatric emergency department - a retrospective cohort study. J Pediatr Pharmacol Ther. 2018;23(6):455-459. 15. Schieveld JN, Staal M, Voogd L, et al. Refractory agitation as a marker for pediatric delirium in very young infants at a pediatric intensive care unit. Intensive Care Med. 2010;36(11):1982-1983. 16. Traube C, Silver G, Gerber LM, et al. Delirium and mortality in critically ill children: epidemiology and outcomes of pediatric delirium. Crit Care Med. 2017;45(5):891-898. 17. Bettencourt A, Mullen JE. Delirium in children: identification, prevention, and management. Crit Care Nurse. 2017;37(3):e9-e18. 18. Suskauer SJ, Trovato MK. Update on pharmaceutical intervention for disorders of consciousness and agitation after traumatic brain injury in children. PM R. 2013;5(2):142-147. 19. Nowicki M, Pearlman L, Campbell C, et al. Agitated behavior scale in pediatric traumatic brain injury. Brain Inj. 2019. doi: 10.1080/02699052.2019.1565893. 20. Mohammad SS, Jones H, Hong M, et al. Symptomatic treatment of children with anti-NMDAR encephalitis. Dev Med Child Neurol. 2016;58(4):376-384. 21. Sonnier L, Barzman D. Pharmacologic management of acutely agitated pediatric patients. Pediatr Drugs. 2011;13(1):1-10. 22. Nordstrom K, Zun LS, Wilson MP, et al. Medical evaluation and triage of the agitated patient: consensus statement of the american association for emergency psychiatry project Beta medical evaluation workgroup. West J Emerg Med. 2012;13(1):3-10. 23. Masters KJ, Bellonci C, Bernet W, et al; American Academy of Child and Adolescent Psychiatry. Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint. J Am Acad Child Adolesc Psychiatry. 2002;41(2 suppl):4S-25S. 24. Croce ND, Mantovani C. Using de-escalation techniques to prevent violent behavior in pediatric psychiatric emergencies: It is possible. Pediatric Dimensions, 2017;2(1):1-2. 25. Marzullo LR. Pharmacologic management of the agitated child. Pediatr Emerg Care. 2014;30(4):269-275. 26. Caldwell B, Albert C, Azeem MW, et al. Successful seclusion and restraint prevention effort in child and adolescent programs. J Psychosoc Nurs Ment Health Serv. 2014;52(11):30-38. 27. De Hert M, Dirix N, Demunter H, et al. Prevalence and correlates of seclusion and restraint use in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry. 2011;20(5):221-230. 28. Crystal S, Olfson M, Huang C, et al. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood). 2009;28(5):w770-w781. 29. American Academy of Child and Adolescent Psychiatry. Practice parameters for the use of atypical antipsychotic medication in children and adolescents. https://www.aacap.org/App_Themes/AACAP/docs/practice_parameters/Atypical_Antipsychotic_Medications_Web.pdf . Accessed March 4, 2019. 30. Lohr WD, Chowning RT, Stevenson MD, et al. Trends in atypical antipsychotics prescribed to children six years of age or less on Medicaid in Kentucky. J Child Adolesc Psychopharmacol. 2015;25(5):440-443. 31. Chen W, Cepoiu-Martin M, Stang A, et al. Antipsychotic prescribing and safety monitoring practices in children and youth: a population-based study in Alberta, Canada. Clin Drug Investig. 2018;38(5):449-455. 32. Deshmukh P, Kulkarni G, Barzman D. Recommendations for pharmacological management of inpatient aggression in children and adolescents. Psychiatry (Edgmont). 2010;7(2):32-40. 33. Haldol [package insert]. Beerse, Belgium: Janssen Pharmaceutica NV; 2005. 34. Hirota T, Veenstra-Vanderweele J, Hollander E, et al. Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis. J Autism Dev Disord. 2014;44(4):948-957. 35. Douglas JF, Sanders KB, Benneyworth MH, et al. Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism spectrum disorder. J Autism Dev Disord. 2013;43(5):1243-1247. 36. Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry. 1996;35(9):1247-1249. 37. Pringsheim T, Hirsch L, Gardner D, et al. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: Psychostimulants, alpha-2 Agonists, and atomoxetine. Can J Psychiatry. 2015;60(2):42-51